SCOTUS reverses Federal Circuit in Life Technologies v Promega

22-02-2017

SCOTUS reverses Federal Circuit in Life Technologies v Promega

JamesBrey / iStockphoto.com

The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement.


SCOTUS, US Court of Appeals for the Federal Circuit, Life Technologies v Promega, genetic testing, patent

LSIPR